COSM
Cosmos Health Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$0.23-1.92%
Price as of Jul 20, 2026
COSM financials
Cosmos Health Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M |
| Cost of revenue | $57.4M | $50.1M | $49.0M | $44.4M |
| Gross profit | $7.9M | $4.3M | $4.3M | $6.0M |
| Operating expenses | $24.4M | $19.9M | $26.2M | $13.4M |
| Operating income | -$16.5M | -$15.5M | -$21.8M | -$7.5M |
| Net income | -$19.1M | -$16.2M | -$18.5M | -$13.8M |
| EBITDA | -$15.2M | -$13.9M | -$17.1M | -$8.9M |
| Basic EPS | $-0.63 | $-1.17 | $-2.15 | $-33.16 |
| Diluted EPS | $-0.63 | $-1.17 | $-2.15 | $-33.16 |
| Balance sheet | ||||
| Cash & equivalents | $715.7K | $315.1K | $3.8M | $20.7M |
| Total assets | $65.5M | $54.3M | $66.0M | $68.0M |
| Total liabilities | $47.1M | $29.8M | $30.0M | $28.4M |
| Stockholders’ equity | $18.4M | $24.5M | $36.0M | $39.7M |
| Total debt | $20.0M | $11.8M | $12.4M | $12.0M |
| Net debt | $19.3M | $11.5M | $8.6M | -$8.7M |
| Cash flow | ||||
| Operating cash flow | -$8.4M | -$7.7M | -$15.6M | -$14.9M |
| Capital expenditure | -$55.7K | -$418.1K | -$9.2M | -$383.1K |
| Free cash flow | -$8.5M | -$8.1M | -$24.8M | -$15.3M |
| Dividends paid | $0.00 | -$6.2M | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | -$100.5K | $0.00 |